Lori A. Hoerrner

Statistics

Publications

Citations

1.4K

H-Index

Active since

1992

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Lund University

National Defense Medical College

Rush University Medical Center

Lori A. Hoerrner is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, joint pathology, and orthopaedic surgery.

Publications per year

1992–2000

Publications

Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.

Michael W. Lark, E K Bayne, J. Flanagan et al. · Journal of Clinical Investigation · 1997 · 472 citations · Full text

Medicine, Orthopaedic Surgery, Pathology +17

Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis

Stefan Lohmander, Lori A. Hoerrner, Michael W. Lark · Arthritis & Rheumatism · 1993 · 335 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +16

Temporal patterns of stromelysin‐1, tissue inhibitor, and proteoglycan fragments in human knee joint fluid after injury to the cruciate ligament or meniscus

Stefan Lohmander, Harald Roos, Leif Dahlberg et al. · Journal of Orthopaedic Research® · 1994 · 170 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +10

The potential role of fibroblasts in periprosthetic osteolysis: Fibroblast response to titanium particles

J. C. Yao, Tibor T. Glant, Michael W. Lark et al. · Journal of Bone and Mineral Research · 1995 · 113 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Cartilage metabolism in the injured and uninjured knee of the same patient.

Leif Dahlberg, Harald Roos, Tore Saxne et al. · Annals of the Rheumatic Diseases · 1994 · 91 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +16

1–5 of 10